-
All we need to know about COVID-19 10
-
What are the differences between the first wave and second wave in India?Lecture1.1
-
How to assess risk Factors for Severe DiseaseLecture1.2
-
How to manage on Day 1 of symptoms with COVID-19?Lecture1.3
-
How to Interpret the Lab Findings in Mild/Moderate/Severe cases:Lecture1.4
-
How to manage patients with information from the lab tests?Lecture1.5
-
When to access need for critical care intervention?Lecture1.6
-
What Investigations may be needed for inpatients?Lecture1.7
-
HRCT in Covid – Indications and importance of HRCT Thorax:Lecture1.8
-
Summary Points in COVID-19 Management.Lecture1.9
-
Do’s and Don’ts in Covid 19:Lecture1.10
-
-
CONCLUSION: 0
The COVID-19 infection has two phases, the first is the viraemic phase and the second one is the immunologic phase. These two have to be promptly identified and managed appropriately as mentioned above. The critical treatments are oxygen therapy when hypoxic and steroids during severe immunologic phase of the disease. Non Invasive Ventilation and other supportive care including appropriate anticoagulation when needed are crucial and may help to avoid ventilation as prognosis by then can be grim with almost 30-50% mortality.
No items in this section
What are the differences between the first wave and second wave in India?
- Age: Though COVID-19 is much severe in the older population, in the second wave there appears to be a shift in the age group of critical patients towards younger age group.
- RtPCR Test false Negatives: (Bypassing rtPCR) New Covid cases may not be detected in some cases by routine RT PCR Tests and had to be relied on symptoms, Serum markers and CT Chest findings.
- Thrombotic complications: More thrombotic complications as compared to the first wave, making it necessary to use anticoagulants.
- Vaccines: Though vaccines are effective after 2 doses, patients are getting admitted with symptoms to the hospital but disease in most cases is asymptomatic or mild.
- Social Strata: Middle to High socioeconomic groups appear to be affected and with higher mortality.
- Comorbidities: Severe disease and death may occur even in the absence of comorbidities, unlike in the first wave.
- Rapid Deterioration: The new strain appears to be more virulent and deterioration may be fast.
- Non Pulmonary: The new variant is no more just a lung disease; it can now be classified as a Thrombo, hyperinflammatory vasculitic disease with lung involvement in the form of ARDS.